Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 14, 2020

SELL
$10.74 - $16.32 $4.12 Million - $6.27 Million
-384,031 Closed
0 $0
Q4 2019

Feb 13, 2020

BUY
$12.94 - $20.58 $129,400 - $205,799
10,000 Added 2.67%
384,031 $5.68 Million
Q2 2019

Aug 14, 2019

BUY
$10.0 - $13.03 $432,310 - $563,299
43,231 Added 13.07%
374,031 $0
Q1 2019

Jun 20, 2019

BUY
$9.47 - $17.01 $3.13 Million - $5.63 Million
330,800 New
330,800 $3.13 Million

Others Institutions Holding HARP

About Harpoon Therapeutics, Inc.


  • Ticker HARP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,106,800
  • Description
  • Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company, engages in the development of a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases in the United States. The company develops tri-specific T cell activating construct (TriTAC) product candi...
More about HARP
Track This Portfolio

Track Sphera Funds Management Ltd. Portfolio

Follow Sphera Funds Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Sphera Funds Management Ltd. with notifications on news.